Search Results for: NTEC
These five stocks trading under the $10 level have big upside to the analysts' price targets. Plus they are all covered with Buy ratings at top firms across Wall Street.
2 years ago
Last Updated: 1 year ago
The top analyst upgrades, downgrades and other research calls from Wednesday include Celgene, Chevron, Exxon Mobil, Frontier Communications, JPMorgan, Lam Research, Procter & Gamble, Square and...
3 years ago
Last Updated: 1 year ago
Source: ThinkstockThe initial public offering (IPO) calendar for this week lists eight companies with plans to enter the public market. Of the five companies that had scheduled IPOs last week, just...
5 years ago
Last Updated: 11 months ago
AGN started as Buy at Jefferies.AW started as Outperform at Credit Suisse.BAY started as Overweight at JPMorgan.CACH cut to Neutral at Merriman Curhan Ford.CIEN started as Outperform at Piper...
13 years ago
by H.S. AyoubBioHealth Investor.com
13 years ago
From BioHealth Investor by H.S. AyoubBioHealth Investor.com Biotechnology NUVELO INC NEW [NUVO] +24.92% NEOSE TECH INC [NTEC] +20.67% CARDIOVASCULAR BIOTH [CVBT.OB] +18.18% CV THERAPEUTICS I [CVTX]...
14 years ago
Biotechnology MICROMET INC [MITI] +16.00% NEOSE TECH INC [NTEC] +13.14% TRUBION PHARMACEUTIC [TRBN] +8.91% CYPRESS BIOSCIENCE [CYPB] +8.80% OBAGI MEDICAL [OMPI] +8.02% Diagnostic Substances...
14 years ago
